Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

bluebird bio Says List Price Of Newly-Approved Gene Therapy Is At $2.8M

-Reuters
byMichael Horton
August 17, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

-Reuters

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0